SouthState’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.1K Hold
9
– – ﹤0.01% 969
2026
Q2
$1.91K Buy
9
+3
+50% +$589 ﹤0.01% 960
2026
Q1
$1.18K Sell
6
-13
-68% -$2.53K ﹤0.01% 1012
2025
Q4
$3.3K Buy
19
+13
+217% +$2.37K ﹤0.01% 881
2025
Q3
$1.14K Sell
6
-4
-40% -$710 ﹤0.01% 1035
2025
Q2
$1.8K Sell
10
-1
-9% -$174 ﹤0.01% 1121
2025
Q1
$1.86K Buy
+11
New +$1.81K ﹤0.01% 1201

Other funds holding DGX

SouthState's DGX Position: Q3 2026 in Review

SouthState held its Quest Diagnostics (DGX) position steady in Q3 2026 at 9 shares worth $2.1K. The position accounts for ﹤0.01% of the portfolio, ranked #969.

SouthState first reported a position in DGX in Q1 2025 and has held it in 7 quarters since. The position peaked at $3.3K in Q4 2025. 984 funds tracked by Wall St. Rank hold DGX as of Q3 2026.

  • SouthState held 9 shares of Quest Diagnostics worth $2.1K as of Q3 2026.
  • SouthState left its Quest Diagnostics share count unchanged in Q3 2026.
  • Quest Diagnostics made up ﹤0.01% of SouthState's portfolio in Q3 2026, its #969 holding.
  • SouthState first reported a position in Quest Diagnostics in Q1 2025 and has held it in 7 quarters since.
  • SouthState's Quest Diagnostics position peaked at $3.3K in Q4 2025.
  • 984 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2026.

Based on SouthState's 13F filing for Q3 2026, filed 9 Nov 2026.